Acute Tumor Lysis Syndrome during Oral Fludarabine Treatment for CLL – a Rare Event that Might Be Observed More Frequently in the Future

Publisher： Karger

E-ISSN： 2296-5262|31|4|157-158

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.4, 2008-03, pp. : 157-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Acute Tumor Lysis Syndrome during Oral Fludarabine Treatment for Chronic Lymphocytic Leukemia. Role of Treatment with Rasburicase

By  

Oncology Research and Treatment, Vol. 31, Iss. 4, 2008-03 ,pp. : 197-199

Karger

Access to resources Recommend Favorite

Acute Tumor Lysis Syndrome – a Rare Complication in the Treatment of Solid Tumors

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 498-499

Karger

Access to resources Recommend Favorite

Acute Tumor Lysis Syndrome after Transarterial Chemoembolization for Well-Differentiated Hepatocellular Carcinoma with Neuroendocrine Features

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 532-535

Karger

Access to resources Recommend Favorite

Management of Hyperleukocytosis and Prevention of Tumor Lysis Syndrome with Low-Dose Prednisone Continuous Infusion in Children with Acute Lymphoblastic Leukemia

By  

Acta Haematologica, Vol. 121, Iss. 1, 2009-04 ,pp. : 56-62

Karger

Access to resources Recommend Favorite

Recombinant Urate Oxidase (Rasburicase) for the Prevention and Treatment of Tumor Lysis Syndrome in Patients with Hematologic Malignancies

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 35-38

Karger

Access to resources Recommend Favorite